COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor

The SARS-CoV-2 spread quickly across the globe. The World Health Organization (WHO) on March 11 declared COVID-19 a pandemic. The mortality rate, hospital disorders and incalculable economic and social damages, besides the unproven efficacy of the treatments evaluated against COVID-19, raised the ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Feitosa, Eduardo L, Júnior, Francisco Tiago Dos S S, Nery Neto, José Arimatéa De O, Matos, Luis F L, Moura, Matheus H De S, Rosales, Thiele Osvaldt, De Freitas, Guilherme Barroso L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484667/
https://www.ncbi.nlm.nih.gov/pubmed/32922174
http://dx.doi.org/10.7150/ijms.48053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484667/
https://www.ncbi.nlm.nih.gov/pubmed/32922174
http://dx.doi.org/10.7150/ijms.48053

Ejemplares similares